08-15-2020, 12:28 PM
[tweet]https://twitter.com/ASlavitt/status/1294654256763609090[/tweet]
Quote:Yale intends to provide its “open source” testing protocol to laboratories around the country. Other labs can now adopt the method while using a variety of commercially available testing components that can reduce costs, speed turnaround times and increase testing frequency, according to the FDA. The Yale researchers have estimated it should cost about $10 to run a test.This test still involves a lab. You have to get the test to the lab and the results back to the patient (and the State of California). While labs can adopt the method, that won't happen overnight. I can almost assure you that no test that involves a back-and-forth to a lab will cost only $10.00. As a patient, you may pay that, but it will cost more. Also note the word "intends". Future tense.
Quote:Yale intends to provide its “open source” testing protocol to laboratories around the country. Other labs can now adopt the method while using a variety of commercially available testing components that can reduce costs, speed turnaround times and increase testing frequency, according to the FDA. The Yale researchers have estimated it should cost about $10 to run a test.This test still involves a lab. You have to get the test to the lab and the results back to the patient (and the State of California). While labs can adopt the method, that won't happen overnight. I can almost assure you that no test that involves a back-and-forth to a lab will cost only $10.00. As a patient, you may pay that, but it will cost more. Also note the word "intends". Future tense.
Quote:The method, called SalivaDirect, is being further validated as a test for asymptomatic individuals through a program that tests players and staff from the National Basketball Association (NBA). SalivaDirect is simpler, less expensive, and less invasive than the traditional method for such testing, known as nasopharyngeal (NP) swabbing. Results so far have found that SalivaDirect is highly sensitive and yields similar outcomes as NP swabbing.
Quote:The method, called SalivaDirect, is being further validated as a test for asymptomatic individuals through a program that tests players and staff from the National Basketball Association (NBA). SalivaDirect is simpler, less expensive, and less invasive than the traditional method for such testing, known as nasopharyngeal (NP) swabbing. Results so far have found that SalivaDirect is highly sensitive and yields similar outcomes as NP swabbing.
(08-16-2020, 08:46 AM)dabigv13 Wrote: If Holmes was just a couple years later with her product, she'd probably be sitting on a lot of government money right about now to try and make her machine work for covid testing.I think you are absolutely right. This thought should give pause to all of us about what is going on during this outbreak. Lots of very questionable decisions will be made. It is an inevitable consequence of the uncertainty we all face. Another reason to be more prepared at all levels in the future.
(08-16-2020, 08:46 AM)dabigv13 Wrote: If Holmes was just a couple years later with her product, she'd probably be sitting on a lot of government money right about now to try and make her machine work for covid testing.I think you are absolutely right. This thought should give pause to all of us about what is going on during this outbreak. Lots of very questionable decisions will be made. It is an inevitable consequence of the uncertainty we all face. Another reason to be more prepared at all levels in the future.
(08-16-2020, 08:46 AM)dabigv13 Wrote: If Holmes was just a couple years later with her product, she'd probably be sitting on a lot of government money right about now to try and make her machine work for covid testing.
(08-16-2020, 08:46 AM)dabigv13 Wrote: If Holmes was just a couple years later with her product, she'd probably be sitting on a lot of government money right about now to try and make her machine work for covid testing.